PI4Kβ/PKG-IN-1
PI4Kβ/PKG-IN-1 (Compound 19) is an orally active dual inhibitor targeting Plasmodium phosphatidylinositol 4-kinase beta (PI4Kβ) and cGMP-dependent protein kinase (PKG) . PI4Kβ/PKG-IN-1 exhibits potent antiplasmodial activity. PI4Kβ/PKG-IN-1 is promising for research of malaria[1].
Product Specifications
UNSPSC
12352005
Target
Parasite; PI4K; PKG
Related Pathways
Anti-infection; PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Infection
Smiles
NC1=NC2=CC(C3=NN(CC4=CC=C(Cl)C(F)=C4)C5=NC=NC(N)=C53)=CC=C2O1
Molecular Formula
C19H13ClFN7O
Molecular Weight
409.80
References & Citations
[1]Gachuhi S, et al. Medicinal Chemistry Progression of Sapanisertib, the Anticancer and Dual Plasmodium Phosphatidylinositol 4-Kinase Beta and cGMP-Dependent Protein Kinase Inhibitor, for Malaria. J Med Chem. 2025 Jun 12;68 (11) :10757-10770.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
